Skip to main content
Caplight Logo









ScreenIn3D

ScreenIn3D

Private
GlasgowHealthcare & Life Scienceshttps://screenin3d.com/

Last Round

Seed

Jun 12, 2025

Total Funding Raised

$1.42M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ScreenIn3D is a biotechnology company that has developed a lab-on-a-chip system for testing cancer therapies on patient-derived tumor samples, offering a faster and more accurate alternative to animal testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

3D tumor profilingmicrofluidic platformdrug discoveryoncology drug developmentcontract research organizationCROdrug efficacy testinglab-on-a-chippreclinical testing3D tumor modelspatient-derived tissueorgan-on-a-chiphigh-throughput screeningprecision medicinein vitro oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ScreenIn3D Comparables

Compare ScreenIn3D with similar companies based on industry and business-model similarity.

ScreenIn3D comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carcinotech
92%
Spanios
88%
MISO Chip
87%

ScreenIn3D Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 12, 2025
GrantFeb 20, 2025
SeedAug 18, 2023

Key People

Founding team and executive leadership

Michele Zagnoni

Chief Executive Officer

Executive Team

ScreenIn3D Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 191% MoM, from 318 to 926.

  • Aug 18, 2023

    $285K round led by Gabriel Investments

ScreenIn3D Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ScreenIn3D Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ScreenIn3D's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow
Employee Range10
Year Founded2018
Last FundingJun 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?